Zacks Investment Research on MSN4d
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Novavax Inc. stock underperforms Thursday when compared to competitors
Shares of Novavax Inc. NVAX slid 6.35% to $5.60 Thursday, on what proved to be an all-around dismal trading session for the ...
The Pharma Letter3h
$175 million milestone in jeopardy as FDA delays Novavax nod
US biotech Novavax (Nasdaq: NVAX) is still waiting on a decision from the Food and Drug Administration over full approval of its protein-based COVID-19 vaccine, despite the agency having set an April ...
Novavax believes BLA ‘ready for approval,’ waiting on action from FDA
Novavax (NVAX) issued the following update on the FDA BLA for the company’s COVID-19 vaccine: “Novavax can confirm that April 1, 2025, was the ...
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views
The health agency’s top immunization official announced the move Monday in protest, citing Secretary Kennedy’s ...
Novavax Inc. stock underperforms Monday when compared to competitors
Shares of Novavax Inc. NVAX slipped 8.43% to $6.41 Monday, on what proved to be an all-around mixed trading session for the ...
Novavax set to snap six days of losses as shares trade in green
Shares of Novavax (NASDAQ:NVAX) were on track to snap six straight days of losses, as the stock rose 2.5% to $6.15 in Wednesday afternoon trade.  The biotech company lost more than 20% in the last six ...
Novavax put volume heavy and directionally bearish
Bearish flow noted in Novavax (NVAX) with 6,544 puts trading, or 7x expected. Most active are 4/4 weekly 6 puts and 4/4 weekly 5 puts, with ...